Figure S1, Table S1, Table S2, Supplementary Methods from Efficient Gene Silencing in Brain Tumors with Hydrophobically Modified siRNAs
Maire F. Osborn(University of Massachusetts Chan Medical School), Anastasia Khvorova(University of Massachusetts Chan Medical School), Miguel Sena‐Esteves(University of Massachusetts Chan Medical School), Jonathan K. Watts(University of Massachusetts Chan Medical School), Andrew H. Coles(University of Massachusetts Chan Medical School), Michael P. Moazami(University of Massachusetts Chan Medical School), Dimas Echeverria(University of Massachusetts Chan Medical School), Diane Golebiowski(University of Massachusetts Chan Medical School)
Cited by 0
Related Papers
RNAi-based drug design: considerations and future directions
|Nature Reviews Drug Discovery|2024|226
Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain
|Neuroscience|2006|200
Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide
|Nature Medicine|2021|173
The Central Nervous System-Restricted Transcription Factor Olig2 Opposes p53 Responses to Genotoxic Damage in Neural Progenitors and Malignant Glioma
|Cancer Cell|2011|156
Requirement of the ATM/p53 Tumor Suppressor Pathway for Glucose Homeostasis
|Molecular and Cellular Biology|2010|118